Rafferty Asset Management, LLC Kymera Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 65,451 shares of KYMR stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,451

Previous 90,820 27.93%

Holding current value

$2.75 Million

Previous $2.71 Million 14.28%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.16 - $52.4 $765,129 - $1.33 Million	-25,369 Reduced 27.93%	65,451 $3.1 Million
Q2 2024 Aug 13, 2024	SELL	$29.85 - $39.42 $3.58 Million - $4.73 Million	-120,041 Reduced 56.93%	90,820 $2.71 Million
Q1 2024 May 13, 2024	BUY	$22.9 - $43.57 $2.08 Million - $3.95 Million	90,672 Added 75.44%	210,861 $8.48 Million
Q4 2023 Feb 13, 2024	SELL	$10.97 - $26.84 $328,112 - $802,784	-29,910 Reduced 19.93%	120,189 $3.06 Million
Q3 2023 Nov 13, 2023	SELL	$13.9 - $23.88 $895,034 - $1.54 Million	-64,391 Reduced 30.02%	150,099 $2.09 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $120,982 - $188,602	5,401 Added 2.58%	214,490 $4.93 Million
Q1 2023 May 11, 2023	SELL	$24.84 - $38.75 $161,112 - $251,332	-6,486 Reduced 3.01%	209,089 $6.2 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $703,208 - $1.11 Million	35,933 Added 20.0%	215,575 $5.38 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $612,725 - $1 Million	29,303 Added 19.49%	179,642 $3.91 Million
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $370,361 - $1.12 Million	26,211 Added 21.12%	150,339 $2.96 Million
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $1 Million - $1.83 Million	28,352 Added 29.6%	124,128 $5.25 Million
Q4 2021 Feb 10, 2022	BUY	$49.91 - $65.56 $2.45 Million - $3.21 Million	49,027 Added 104.87%	95,776 $6.08 Million
Q3 2021 Nov 10, 2021	SELL	$47.8 - $66.66 $231,925 - $323,434	-4,852 Reduced 9.4%	46,749 $2.75 Million
Q2 2021 Aug 10, 2021	SELL	$31.08 - $51.95 $6,495 - $10,857	-209 Reduced 0.4%	51,601 $2.5 Million
Q1 2021 May 10, 2021	BUY	$35.64 - $85.46 $1.85 Million - $4.43 Million	51,810 New	51,810 $2.01 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Kymera Therapeutics, Inc. Transaction History